<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    boon, Inc.

    boon, Inc.

    Boon, Inc. offers on-demand temporary dental, veterinary and medical staffing via ...

    Boon, Inc. offers on-demand temporary dental, v...

    Amount Raised:    $143,161
    Filing Type:    CF
    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    AnaptysBio, Inc.

    AnaptysBio, Inc.

    AnaptysBio is a clinical-stage antibody development company advancing therapeutic ...

    AnaptysBio is a clinical-stage antibody develop...

    Filing Type:    PU
    Cytonics Corp

    Cytonics Corp

    Cytonics, founded in 2006, is a private research and development company focused o...

    Cytonics, founded in 2006, is a private researc...

    Amount Raised:    $3,300,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Hoya Corp.

    Hoya Corp.

    Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company, and a leading ...

    Founded in 1941 in Tokyo, Japan, Hoya is a glob...

    Filing Type:    PU
    Cerus Corporation

    Cerus Corporation

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply a...

    Cerus Corporation is dedicated solely to safegu...

    Filing Type:    PU
    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing ...

    Trillium Therapeutics Inc. is a clinical stage ...

    Filing Type:    PU
    Neoleukin Therapeutics, Inc.

    Neoleukin Therapeutics, Inc.

    Neoleukin is a biopharmaceutical company creating next generation immunotherapies ...

    Neoleukin is a biopharmaceutical company creati...

    Filing Type:    PU
    BeyondSpring, Inc.

    BeyondSpring, Inc.

    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-...

    Headquartered in New York, BeyondSpring Inc. (B...

    Filing Type:    PU
    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the ...

    Salarius Pharmaceuticals, Inc. is a clinical-st...

    Filing Type:    PU
    Sunesis Pharmaceuticals, Inc.

    Sunesis Pharmaceuticals, Inc.

    Sunesis is a biopharmaceutical company focused on the development and commercializ...

    Sunesis is a biopharmaceutical company focused ...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.